Pharmaceutics

This page contains key pharmaceutical news on drug recalls, FDA clearance, safety communications and research. In cardiology, key pharmaceutic agents include antiplatelet therapies, anticoagulants, hypertension drugs, and drugs for heart failure and arrhythmias.

AHA data challenge explores links between inflammation and heart disease
Are care teams doing enough to take on inflammation? The American Heart Association hopes this new research initiative can help answer that question, and many others.
Yes, researchers argue, vitamin D supplements help protect the heart
The ongoing debate continues. The team behind this latest analysis pointed to more than 40 years of research to make its point.
FDA approves Bayer's finerenone to treat wide range of heart failure patients
Finerenone, sold by Bayer under the brand name Kerendia, is now approved in the United States for the treatment of HFmrEF and HFpEF. The drug has already been used for years to treat patients with chronic kidney disease and type 2 diabetes.
Statin use may protect patients from subarachnoid hemorrhages
Statins appear to be the most impactful for patients diagnosed with hypertension or cerebrovascular disease.
FDA grants breakthrough therapy designation to new drug candidate for FA cardiomyopathy
The new drug, LX2006, has already received the FDA's fast track designation. This latest distinction was based on early data from two separate clinical trials.

NSAID use may not be safe for older patients with type 2 diabetes

The new analysis, based on data from more than 330,000 patients, is scheduled to be presented during ESC Congress 2022.

Medical marijuana linked to a higher risk of heart rhythm issues

The new analysis, presented at ESC Congress 2022, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk.

CVS, Walgreens and Walmart ordered to pay $650M for role in opioid epidemic

Three major pharmacy names will have to fork over hundreds of millions of dollars to two Ohio counties for their roles in the opioid epidemic, a judge has ruled.

Merck Januvia Janumet Steglujan Nitroso-STG-19 (NTTP) type 2 diabetes

Possible carcinogen detected in multiple type 2 diabetes medications

To avoid a potential shortage, FDA officials have said the medications can be sold to patients on a temporary basis.

SAPT after TAVR preferred over DAPT, new meta-analysis confirms

An international team of researchers, led by specialists from Cleveland Clinic, found that DAPT was consistently linked to a greater risk of major or life-threatening bleeding events.

This latest shortage involves dobutamine, an injectable medication often prescribed for advanced heart failure and cardiogenic shock. It is also a central component of dobutamine stress echocardiography (DSE), a test used to evaluate patients with severe aortic stenosis.

A new supply issue hits cardiology: 5 recommendations for cardiologists during the dobutamine shortage

The shortage could lead to significant issues for cardiologists. The American College of Cardiology provided some words of wisdom on the ongoing issue.

Programmable RNA-DNA anticoagulant fibers may provide a better balance between blood clots and bleeding risks

“We can learn from nature, but we have built something that has never been introduced before,” one researcher said.

Autoimmune patients caught in crossfire of Supreme Court's Roe decision

Some patients with certain autoimmune diseases are finding it difficult to obtain their prescriptions for methotrexate as a result of changing abortion care laws.

Pharmaceutics

AHA data challenge explores links between inflammation and heart disease

Yes, researchers argue, vitamin D supplements help protect the heart

FDA approves Bayer's finerenone to treat wide range of heart failure patients

Statin use may protect patients from subarachnoid hemorrhages

FDA grants breakthrough therapy designation to new drug candidate for FA cardiomyopathy